2-(pyridin-4-yl)-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-one | 1321936-84-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 英文名称: 2-(pyridin-4-yl)-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-one
• 英文别名: 2-pyridin-4-yl-6,7-dihydro-5H-thieno[3,2-c]pyridin-4-one
• CAS: 1321936-84-8
• 化学式: C₁₂H₁₀N₂OS
• 分子量: 230.29
• InChiKey: PMWUFVINBCBWQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  70.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  在 sodium azide 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 甲烷磺酸 、 sodium carbonate 作用下， 以 乙二醇二甲醚 、 1,1-二氯乙烷 、 二氯甲烷 为溶剂， 反应 6.0h， 生成 2-(pyridin-4-yl)-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-one
  参考文献：
  名称：

  3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors

  摘要：

  A ligand-based 3D pharmacophore model for serine/threonine kinase CDC7 inhibition was created and successfully applied in the discovery of novel 2-(heteroaryl)-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-ones. The pharmacophore model provided a hypothesis for lead generation missed by docking to a homology model. Medicinal chemistry exploration of the series revealed clear structure-activity relationships consistent with the pharmacophore model and pointed to further optimization opportunities.

  DOI：

  10.1021/ml200029w

文献信息

• 3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors
  作者：Mika Lindvall、Christopher McBride、Maureen McKenna、Thomas G. Gesner、Asha Yabannavar、Kent Wong、Song Lin、Annette Walter、Cynthia M. Shafer

  DOI：10.1021/ml200029w

  日期：2011.10.13

  A ligand-based 3D pharmacophore model for serine/threonine kinase CDC7 inhibition was created and successfully applied in the discovery of novel 2-(heteroaryl)-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-ones. The pharmacophore model provided a hypothesis for lead generation missed by docking to a homology model. Medicinal chemistry exploration of the series revealed clear structure-activity relationships consistent with the pharmacophore model and pointed to further optimization opportunities.